Stock RLMD RELMADA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Relmada Therapeutics, Inc.

Equities

RLMD

US75955J4022

Real-time Estimate Cboe BZX
Other stock markets
 09:50:53 14/05/2024 pm IST 		5-day change 1st Jan Change
3.635 USD +2.97% Intraday chart for Relmada Therapeutics, Inc. -4.32% -11.71%
08/05 Transcript : Relmada Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024
08/05 Relmada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
RELMADA THERAPEUTICS, INC. Stock Relmada Therapeutics, Inc.
 107M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 22.34B -
ARGENX SE Stock argenx SE
 21.93B -
GENMAB A/S Stock Genmab A/S
 18.59B
  1. Stock Market
  2. Equities
  3. RLMD Stock
  4. Charts Relmada Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW